Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT
Journal
Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060
Informations de publication
Date de publication:
23 03 2020
23 03 2020
Historique:
pubmed:
23
2
2020
medline:
22
6
2021
entrez:
21
2
2020
Statut:
ppublish
Résumé
Ergotamine (ERG) and dihydroergotamine (DHE), common migraine drugs, have small structural differences but lead to clinically important distinctions in their pharmacological profiles. For example, DHE is less potent than ERG by about 10-fold at the 5-hydroxytrptamine receptor 1B (5-HT
Identifiants
pubmed: 32078320
doi: 10.1021/acs.jcim.9b01082
doi:
Substances chimiques
Receptors, Serotonin
0
Serotonin
333DO1RDJY
Dihydroergotamine
436O5HM03C
Ergotamine
PR834Q503T
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM